Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
4.83 USD | +3.65% | -0.41% | -4.55% |
Sales 2024 * | 76.38M 104M | Sales 2025 * | 52.83M 72.17M | Capitalization | 570M 779M |
---|---|---|---|---|---|
Net income 2024 * | -119M -163M | Net income 2025 * | -141M -193M | EV / Sales 2024 * | 5.35 x |
Net cash position 2024 * | 161M 220M | Net cash position 2025 * | 67.89M 92.76M | EV / Sales 2025 * | 9.5 x |
P/E ratio 2024 * |
-4.61
x | P/E ratio 2025 * |
-4.36
x | Employees | 267 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 81.8% |
Latest transcript on Wave Life Sciences Ltd.
1 day | +3.43% | ||
1 week | -0.41% | ||
Current month | -21.88% | ||
1 month | -23.61% | ||
3 months | +7.83% | ||
6 months | -11.23% | ||
Current year | -4.55% |
Managers | Title | Age | Since |
---|---|---|---|
Paul Bolno
CEO | Chief Executive Officer | 50 | 13-11-30 |
Kyle Moran
DFI | Director of Finance/CFO | 54 | 14-06-30 |
Chandra Vargeese
CTO | Chief Tech/Sci/R&D Officer | 63 | 14-07-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Christian Henry
CHM | Chairman | 56 | 16-11-09 |
Mark Corrigan
BRD | Director/Board Member | 66 | 19-09-03 |
Adrian Rawcliffe
BRD | Director/Board Member | 52 | 17-01-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.04% | 0 M€ | 0.00% | - | |
0.02% | 0 M€ | 0.00% | - | |
0.00% | 34 M€ | +2.43% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-29 | 4.83 | +3.65% | 384 801 |
24-04-26 | 4.66 | -1.69% | 407,036 |
24-04-25 | 4.74 | -5.39% | 397,715 |
24-04-24 | 5.01 | -1.38% | 430,676 |
24-04-23 | 5.08 | +4.96% | 469,439 |
Delayed Quote Nasdaq, April 29, 2024 at 03:55 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-4.55% | 570M | |
-2.73% | 103B | |
+1.56% | 95.28B | |
+1.46% | 22.15B | |
-16.57% | 21.02B | |
-8.58% | 18.15B | |
-38.74% | 16.73B | |
-12.95% | 16.05B | |
+5.26% | 13.68B | |
+33.88% | 12.17B |
- Stock Market
- Equities
- WVE Stock